Streetbeat News

Price Targets

VCYT

Needham analyst Mike Matson maintains a Buy rating on Veracyte and raises the price target from $31 to $37.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 9:29 am

AVAV

Baird analyst Peter Arment has upgraded AeroVironment (NASDAQ:AVAV) from Neutral to Outperform and increased the price target from $161 to $220.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 9:28 am

DKS

Baird analyst Justin Kleber maintains a Neutral rating on Dick's Sporting Goods (NYSE:DKS) with a price target of $235.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 9:26 am

NCNO

Piper Sandler analyst Brent Bracelin has reiterated an Overweight rating on Ncino (NASDAQ:NCNO) and maintained a price target of $38.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 9:04 am

CGON

Roth MKM has initiated coverage on CG Oncology with a Buy rating and set a price target of $65.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 10:24 pm

REPL

Roth MKM has initiated coverage on Replimune Group with a Buy rating and set a price target of $17.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 10:22 pm

A

Wells Fargo has initiated coverage on Agilent Technologies with an Overweight rating and set a price target of $157.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 10:16 pm

TMO

Wells Fargo has initiated coverage on Thermo Fisher Scientific with an Overweight rating and set a price target of $670.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 10:14 pm

MYGN

Wells Fargo has initiated coverage on Myriad Genetics with an Overweight rating and set a price target of $35.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 10:12 pm

EXAS

Wells Fargo has initiated coverage on Exact Sciences with an Overweight rating and set a price target of $75.

Portfolio Pulse from Benzinga Newsdesk

August 27, 2024 | 10:11 pm